Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$12,434,490
+$2,849,568 QoQ
Shares Held
10,367
-0.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.64%
of 13F equity value
Holder Rank
#1,138
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Essex Bank holds $41,161,477 across 11 Drug Manufacturers - General names. LLY ranks #2 (30.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
67,809 | $17,221,451 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
10,367 | $12,434,490 | |
| 3 | MRK |
Merck & Co., Inc.
|
28,245 | $3,629,482 | |
| 4 | ABBV |
AbbVie Inc.
|
13,631 | $3,430,104 | |
| 5 | AMGN |
Amgen Inc
|
2,520 | $912,541 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
13,528 | $779,482 | |
| 7 | NVS |
Novartis AG
|
4,797 | $751,785 | |
| 8 | PFE |
Pfizer Inc
|
24,466 | $589,140 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,434,490 | 10,367 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $9,584,922 | 10,421 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $11,629,113 | 10,821 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $8,566,964 | 11,228 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $9,010,586 | 11,559 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $9,961,299 | 12,061 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $8,533,688 | 11,054 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $10,035,927 | 11,328 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $11,004,893 | 12,155 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $9,519,118 | 12,236 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $7,132,608 | 12,236 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $6,584,676 | 12,259 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $5,883,353 | 12,545 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $4,296,871 | 12,512 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $4,804,941 | 13,134 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $4,316,075 | 13,348 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $4,320,364 | 13,325 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $3,846,807 | 13,433 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $3,707,976 | 13,424 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $3,101,845 | 13,425 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $3,151,768 | 13,732 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $2,568,774 | 13,750 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $2,324,419 | 13,767 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $2,039,715 | 13,780 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $2,240,892 | 13,649 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $1,886,452 | 13,599 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||